Relationship between various measures of bone mineral density and the prevalence of vertebral fractures in cardiac transplant recipients

Swiss Medical Weekly

Volumn 134, Issue 15-16, 2004, Pages 215-220

  Höfle, Günter ^a   Saely, C H ^a   Tautermann, G ^a   Aczel S ^a   Holzmuller H ^a   Drexel, H ^a  

^a Landeskrankenhaus Feldkirch   (Austria)

Author keywords

Bone turnover marker; Osteodensitometry; Osteoporosis; Post transplantation bone disease; Quantitative heel ultrasound

Indexed keywords

AZATHIOPRINE; CALCIUM; COLECALCIFEROL; CYCLOSPORIN A; PREDNISONE;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; BONE TURNOVER; CALCANEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITOMETRY; DISEASE ASSOCIATION; DISEASE MARKER; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; FEMALE; FEMUR NECK FRACTURE; HEART TRANSPLANTATION; HIP; HUMAN; INCIDENCE; LUMBAR SPINE; MALE; OSTEOPENIA; OSTEOPOROSIS; POSTOPERATIVE PERIOD; PREVALENCE; SPINE RADIOGRAPHY; VERTEBRA FRACTURE;

EID: 2442711261     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Rodino MA, Shane, E, Osteoporosis after organ transplantation. Am J Med 1998;104:459-69.
2. Lee AH, Mull RL, Keenan GF, Callegari PE, Dalinka MK, Eisen HJ, et al. Osteoporosis and bone morbidity in cardiac transplant recipients. Am J Med 1994;96:35-41.
3. Meys E, Terreaux-Duvert F, Beaume-Six T, Dureau G, Meunier PJ. Bone loss after cardiac transplantation: effects of calcium, calcidiol and monofluorophosphate. Osteoporos Int 1993;3:322-9.
4. Shane E, Rivas MC, Silverberg SJ, Kim TS, Staron RB, Bilezikian JP. Osteoporosis after cardiac transplantation. Am J Med 1993;94:257-64.
5. van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) 2000;39:1383-9.
6. Cvetkovic M, Mann GN, Romero DF, Liang XG, Ma Y, Jee WS, et al. The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo. Transplantation 1994;57:1231-7.
7. Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S. Cyclosporine-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration. Endocrinology 1988;123:2571-7.
8. Thiebaud D, Krieg MA, Gillard-Berguer D, Jacquet AF, Goy JJ, Burckhardt P. Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation. Eur J Clin Invest 1996;26:549-55.
9. Guo CY, Johnson A, Locke TJ, Eastell R. Mechanisms of bone loss after cardiac transplantation. Bone 1998;22:267-71.
10. Legrand E, Chappard D, Pascaretti C, Duquenne M, Rondeau C, Simon Y, et al. Bone mineral density and vertebral fractures in men. Osteoporos Int 1999;10:265-70.
11. Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K, et al. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet 1993;341:72-5.
12. Torgerson DJ, Campbell MK, Thomas RE, Reid DM. Prediction of perimenopausal fractures by bone mineral density and other risk factors. J Bone Miner Res 1996;11:293-7.
13. Selby PL, Halsey JP, Adams KR, Klimiuk P, Knight, SM, Pal B, et al. Corticosteroids do not alter the threshold for vertebral fracture. J Bone Miner Res 2000;15:952-6.
14. Walsh LJ, Lewis SA, Wong CA, Cooper S, Oborne J, Cawte SA, et al. The impact of oral corticosteroid use on bone mineral density and vertebral fracture. Am J Respir Crit Care Med 2002;166:691-5.
15. Leidig-Bruckner G, Hosch S, Dodidou P, Ritschel D, Conradt C, Klose C, et al. Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet 2001;357:342-7.
16. Hans D, Dargent-Molina P, Schott AM, Sebert JL, Cormier C, Kotzki PO, et al. Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet 1996;348:511-4.
17. Schott AM, Weill-Engerer S, Hans D, Duboeuf F, Delmas PD, Meunier PJ. Ultrasound discriminates patients with hip fracture equally well as dual energy X-ray absorptiometry and independently of bone mineral density. J Bone Miner Res 1995;10:243-9.
18. Daens S, Peretz A, de Maertelaer V, Moris M, Bergmann P. Efficiency of quantitative ultrasound measurements as compared with dual-energy X-ray absorptiometry in the assessment of corticosteroid-induced bone impairment. Osteoporos Int 1999;10:278-83.
19. Miller PD, Siris ES, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA, et al. Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment. J Bone Miner Res 2002;17:2222-30.
20. Faulkner KG, von Stetten E, Miller P. Discordance in patient classification using T-scores. J Clin Densitom 1999;2:343-50.
21. Grampp S, Genant HK, Mathur A, Lang P, Jergas M, Takada M et al. Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification. J Bone Miner Res 1997;12:697-711.
22. Billingham ME, Cary NR, Hammond ME, Kemnitz J, Marboe C, McCallister HA et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990;9:587-93.
23. Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-41.
24. Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993;8:1137-48.
25. Kiel D. Assessing vertebral fractures. National Osteoporosis Foundation Working Group on Vertebral Fractures. J Bone Miner Res 1995;10:518-23.
26. Mezquita-Raya P, Munoz-Torres M, Luna JD, Luna V, Lopez-Rodriguez F, Torres-Vela E, et al. Relation between vitamin D insufficiency, bone density, and bone metabolism in healthy postmenopausal women. J Bone Miner Res 2001;16:1408-15.
27. Kroger H, Lunt M, Reeve J, Dequeker J, Adams JE, Birkenhager JC, et al. Bone density reduction in various measurement sites in men and women with osteoporotic fractures of spine and hip: the European quantification of osteoporosis study. Calcif Tissue Int 1999;64:191-9.
28. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996;312:1254-9.
29. Masud T, Langley S, Wiltshire P, Doyle DV, Spector TD. Effect of spinal osteophytosis on bone mineral density measurements in vertebral osteoporosis. BMJ 1993;307:172-3.
30. Shane E, Rivas MC, Silverberg SJ, Kim TS, Staron RB, Bilezikian JP. Osteoporosis After Cardiac Transplantation. Am J Med 1993;94:257-64.
31. Van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C. Bone density threshold and other predictors of vertebral fractures in patients receiving oral glucocorticosteroid therapy. Arthritis Rheum 2003;48:3224-9.
32. Peretz A, De Maertelaer V, Moris M, Wouters M, Bergmann P. Evaluation of quantitative ultrasound and dual X-Ray absorptiometry measurements in women with and without fractures. J Clin Densitom 1999;2:127-33.
33. Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res 2000;15:1526-36.
34. Oaks TE, Wannenberg T, Close SA, Tuttle LE, Kon ND. Steroid-free maintenance immunosuppression after heart transplantation. Ann Thorac Surg 2001;72:102-6.